DC Klonoff - Diabetes Care, 2005 - ncbi.nlm.nih.gov 1: Diabetes Care. 2005 May;28(5):1231-9. Continuous glucose monitoring: roadmap for 21st
century diabetes therapy. Klonoff DC. Mills-Peninsula Health Services Diabetes Research Institute,
100 S. San Mateo Dr., Rm. 3124, San Mateo, CA 94401, USA. klonoff@itsa.ucsf.edu. ... Cited by 171 - Related articles - All 3 versions
M Bayes, X Rabasseda, JR Prous - Methods and findings in …, 2006 - journals.prous.com Contributing Editors: P. Cole, C. Orellana, JA Vallès, RM a . Antonijoan, KP Mohana Priya,
M. Priya, V. Renuga, R. Sree Lekha, B. Priya, A. Tomillero, G. Krithiga and E. Banu Rekha. Cited by 148 - Related articles - All 9 versions
RE Ratner, R Dickey, M Fineman, DG Maggs, … - Diabetic …, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 111 - Related articles - BL Direct - All 5 versions
I Chapman, B Parker, S Doran, C Feinle-Bisset, J … - Diabetologia, 2005 - Springer Page 1. Diabetologia (2005) 48: 838–848 DOI 10.1007/s00125-005-1732-4 ARTICLE
I. Chapman . B. Parker . S. Doran . C. Feinle-Bisset . J. Wishart . S. Strobel . Y. Wang .
C. Burns . C. Lush . C. Weyer . M. Horowitz Effect of ... Cited by 85 - Related articles - All 5 versions
- ►diabetesjournals.org O Schmitz, B Brock, J Rungby - Diabetes, 2004 - Am Diabetes Assoc Amylin is a peptide hormone that is cosecreted with insulin from the pancreatic ß-cell and is thus
deficient in diabetic people. It inhibits glucagon secretion, delays gastric emptying, and acts as
a satiety agent. Amylin replacement could therefore possibly improve glycemic control in ... Cited by 76 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org C Weyer, A Gottlieb, DD Kim, K Lutz, S Schwartz, M … - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In this randomized, single-blind,
placebo-controlled, five-way crossover study, 19 subjects with type 1 diabetes using regular
insulin and 21 subjects with type 1 diabetes using insulin lispro underwent five ... Cited by 58 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org A Ceriello, L Piconi, L Quagliaro, Y Wang, CA … - Diabetes Care, 2005 - Am Diabetes Assoc OBJECTIVE—Oxidative stress has been shown to be increased in the postprandial period in
patients with diabetes and has been implicated in the pathogenesis of micro- and macrovascular
complications. The aim of this post hoc analysis was to assess the effects of pramlintide, ... Cited by 55 - Related articles - All 6 versions
GI Uwaifo, RE Ratner - Endocrinology and metabolism clinics of North America, 2005 - Elsevier Since the discovery of insulin by Banting and Best in the early 20th century, the clinical management
of diabetes has undergone significant changes. The last decade has been associated with an
explosion in therapeutic options for management of type 2 diabetes that has significantly ... Cited by 38 - Related articles - All 3 versions
BP Kovatchev, WL Clarke, M Breton, K … - Diabetes Technology …, 2005 - liebertonline.com BORIS P. KOVATCHEV, Ph.D., WILLIAM L. CLARKE, MD, MARC BRETON, Ph.D., KENNETH
BRAYMAN, MD, and ANTHONY MCCALL, MD, Ph.D. ... Background: Continuous glucose monitors
(CGMs) collect detailed blood glucose (BG) time series, which carry significant ... Cited by 40 - Related articles - BL Direct - All 3 versions
